EXOZYMES INC. Increase (Decrease) in Accrued Taxes Payable
EXOZYMES INC. (EXOZ) reported Increase (Decrease) in Accrued Taxes Payable of -$42.27 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedTaxesPayable · last filed 2026-03-30
- EXOZYMES INC. increase (decrease) in accrued taxes payable for the quarter ending 2024-12-31 was $0.00.
- EXOZYMES INC. increase (decrease) in accrued taxes payable for the quarter ending 2024-09-30 was $0.00.
- EXOZYMES INC. increase (decrease) in accrued taxes payable for the quarter ending 2024-06-30 was -$40.92K.
- EXOZYMES INC. increase (decrease) in accrued taxes payable for the quarter ending 2024-03-31 was -$1.34K.
- EXOZYMES INC. increase (decrease) in accrued taxes payable for fiscal 2024 was -$42.27K.
- EXOZYMES INC. increase (decrease) in accrued taxes payable for fiscal 2023 was -$21.29K.
| Period end | Increase (Decrease) in Accrued Taxes Payable 3 month | Increase (Decrease) in Accrued Taxes Payable 6 month | Increase (Decrease) in Accrued Taxes Payable 9 month | Increase (Decrease) in Accrued Taxes Payable 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | -$40.92K derived: sum of 3 quarters · filed 2026-03-30 | -$42.27K 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$40.92K derived: sum of 2 quarters · filed 2025-11-13 | -$42.27K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$40.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$42.27K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | -$1.34K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$21.29K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |